Mo-IPQA at a concentration of 10 μM was effective for up to 48 h after addition (Supplementary Figure S9A) and completely abolished the phosphorylation of EGFR in EGF-stimulated HCC1954 breast cancer cells (Supplementary Figure S9B), whereas its effect was limited at a concentration of 20 μM in the MDA-MB-231 breast cancer cell line. The gene discussed is EGFR; the disease is breast cancer.